Tratamiento con letermovir en participantes pediátricos después de un trasplante alogénico de células madre hematopoyéticas
The primary objective of this study is to evaluate the pharmacokinetics (PK) of letermovir (LET) in pediatric participants. Participants will be enrolled in the following 3 age groups: Age Group 1: